Goldman Sachs Starts Lumiradx Ltd. (LMDX) at Neutral, 'driving diagnostic decentralization takes time & resources'
Tweet Send to a Friend
Goldman Sachs analyst Matthew Sykes initiates coverage on Lumiradx Ltd. (NASDAQ: LMDX) with a Neutral rating and a price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
